tiprankstipranks
Nautilus Biotechnology: Hold Rating Amid Delayed Launch and Strategic Adjustments
PremiumRatingsNautilus Biotechnology: Hold Rating Amid Delayed Launch and Strategic Adjustments
3M ago
Nautilus Biotechnology’s Earnings Call: Progress Amid Challenges
Premium
Company Announcements
Nautilus Biotechnology’s Earnings Call: Progress Amid Challenges
4M ago
Nautilus Biotechnology price target lowered to $2.50 from $4 at Guggenheim
Premium
The Fly
Nautilus Biotechnology price target lowered to $2.50 from $4 at Guggenheim
4M ago
Nautilus Biotechnology downgraded to Sell from Neutral at Goldman Sachs
PremiumThe FlyNautilus Biotechnology downgraded to Sell from Neutral at Goldman Sachs
7M ago
Nautilus Biotechnology Faces ESG Challenges Amid Regulatory Pressure and Investor Scrutiny
Premium
Company Announcements
Nautilus Biotechnology Faces ESG Challenges Amid Regulatory Pressure and Investor Scrutiny
8M ago
Nautilus Biotechnology Reports Q3 2024 Financial Results
Premium
Company Announcements
Nautilus Biotechnology Reports Q3 2024 Financial Results
8M ago
Is NAUT a Buy, Before Earnings?
PremiumPre-EarningsIs NAUT a Buy, Before Earnings?
11M ago
Nautilus Biotechnology initiated with a Buy at Guggenheim
Premium
The Fly
Nautilus Biotechnology initiated with a Buy at Guggenheim
12M ago
Nautilus Biotechnology initiated with a Buy at Guggenheim
Premium
The Fly
Nautilus Biotechnology initiated with a Buy at Guggenheim
12M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100